[go: up one dir, main page]

WO2006101909A3 - Combination therapy for treating or preventing diseases - Google Patents

Combination therapy for treating or preventing diseases Download PDF

Info

Publication number
WO2006101909A3
WO2006101909A3 PCT/US2006/009359 US2006009359W WO2006101909A3 WO 2006101909 A3 WO2006101909 A3 WO 2006101909A3 US 2006009359 W US2006009359 W US 2006009359W WO 2006101909 A3 WO2006101909 A3 WO 2006101909A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating
preventing diseases
combination therapy
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/009359
Other languages
French (fr)
Other versions
WO2006101909A2 (en
Inventor
Steven A Kates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISCHEMIX Inc
Original Assignee
ISCHEMIX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISCHEMIX Inc filed Critical ISCHEMIX Inc
Publication of WO2006101909A2 publication Critical patent/WO2006101909A2/en
Publication of WO2006101909A3 publication Critical patent/WO2006101909A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to compositions useful for treating or preventing diseases or conditions, including in particular, ischemia, wherein the compositions comprise a therapeutically effective amount of a peptide compound in combination with DMSO. The present invention also relates to methods of administering such compositions for treating or preventing ischemia and methods of preparing such compositions.
PCT/US2006/009359 2005-03-16 2006-03-14 Combination therapy for treating or preventing diseases Ceased WO2006101909A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66219605P 2005-03-16 2005-03-16
US60/662,196 2005-03-16

Publications (2)

Publication Number Publication Date
WO2006101909A2 WO2006101909A2 (en) 2006-09-28
WO2006101909A3 true WO2006101909A3 (en) 2006-12-21

Family

ID=37024361

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/009359 Ceased WO2006101909A2 (en) 2005-03-16 2006-03-14 Combination therapy for treating or preventing diseases

Country Status (1)

Country Link
WO (1) WO2006101909A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890896B1 (en) 1999-11-18 2005-05-10 Ceremedix, Inc. Compositions and methods for counteracting effects of reactive oxygen species and free radicals
EP1957093B1 (en) 2005-08-29 2017-04-12 SHASHOUA, Victor E. Neuroprotective and neurorestorative methods and compositions
US7928067B2 (en) 2009-05-14 2011-04-19 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
KR20140020840A (en) 2010-11-18 2014-02-19 이쉐믹스 엘엘씨 Lipoyl compounds and their use for treating ischemic injury
AU2018258158A1 (en) 2017-04-25 2019-11-21 Ischemix Llc Compositions and methods for treating traumatic brain injury
CN112584866A (en) * 2018-07-20 2021-03-30 北京蔚蓝之源医药科技有限公司 Application of sulfoxide compound in preventing radioactive oral mucositis and related radiotherapy complications

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092781A2 (en) * 2001-05-17 2002-11-21 Ceremedix, Inc. Peptide compounds for counteracting reactive oxygen species and free radicals
US6562345B1 (en) * 1996-11-12 2003-05-13 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562345B1 (en) * 1996-11-12 2003-05-13 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus
WO2002092781A2 (en) * 2001-05-17 2002-11-21 Ceremedix, Inc. Peptide compounds for counteracting reactive oxygen species and free radicals

Also Published As

Publication number Publication date
WO2006101909A2 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
WO2007093183A3 (en) Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
WO2008048589A3 (en) Compounds and methods for treatment of hcv
WO2008097640A8 (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
MX2007009649A (en) Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer.
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2010017545A3 (en) Triazole compounds that modulate hsp90 activity
WO2008124085A3 (en) Methods of using combinations of mek and jak-2 inhibitors
WO2007139967A3 (en) Triazole compounds that modulate hsp90 activity
WO2007139955A8 (en) Triazole compounds that modulate hsp90 activity
WO2007094819A8 (en) Triazole compounds that modulate hsp90 activity
WO2007139968A3 (en) Triazole compounds that modulate hsp90 activity
WO2006044775A3 (en) Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
MX2007005590A (en) Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof.
WO2009002808A3 (en) Quinazolinone compounds and methods of use thereof
EP3276004A3 (en) Methods for treating chronic kidney disease
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
WO2006124012A3 (en) Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production
WO2007005300A3 (en) Treatment of dry eye
WO2007009120A3 (en) Heterotetracyclic compounds as tpo mimetics
WO2007022408A3 (en) Combination methods of saha and targretin for treating cancer
WO2008103378A3 (en) Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
WO2007019153A3 (en) Methods for treating hypertension
WO2007022269A3 (en) Compounds and compositions as tpo mimetics

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06738422

Country of ref document: EP

Kind code of ref document: A2